PPARs as molecular targets for drug discovery

Hiroyuki Kagechika, Hiroyuki Miyachi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-inducible transcription factors. PPARs form the heterodimers with retinoid X receptors (RXRs), and modulate specific gene expressions related to the lipid and carbohydrate metabolism. Since fibrate-type lipid-lowering agents and thiazolidinedione (TZD)-type antidiabetic agents are identified as PPARalpha and gamma agonists, respectively, a number of ligands for PPARs have been developed, including PPAR subtype-selective and dual agonists. Recent report that RXR antagonist exhibited antidiabetic and antiobestic activities in animal model experiments, PPARs partial agonists, antagonists, and RXR antagonists have been also synthesized and their function in vivo are under investigations. In this paper, recent studies on the ligands for the PPAR-RXR heterodimers are reviewed.

Original languageEnglish
Pages (from-to)549-555
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume63
Issue number4
Publication statusPublished - Apr 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'PPARs as molecular targets for drug discovery'. Together they form a unique fingerprint.

  • Cite this